Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KLAC vs GSK✓SelectedUSD · GSKKLAC vs GSK performance historyLatest closeAs of-3.17%11/13
Stock and ETF performance explorer

KLAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+195.3%
GSK return
+65.8%
Excess return
+129.5%
Maximum drawdown
-56.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%+0.5%-3.7%-3.2%
7D+10.0%+1.1%+8.8%+9.9%
30D-14.8%+6.3%-21.2%-15.1%
3M-27.2%+1.8%-29.0%-27.2%
6M-17.5%+1.7%-19.1%-17.7%
YTD+25.8%+6.5%+19.3%+24.9%
1Y+31.8%+9.5%+22.3%+30.3%
3Y+195.3%+65.3%+130.0%+179.7%
All+195.3%+65.8%+129.5%+179.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling